Profil
Raphaël Ortiz is currently the Chief Executive Officer-Telix International at Telix Pharmaceuticals Ltd. He is also a Co-Managing Director at Rhine Pharma GmbH.
Previously, he worked as the Head-Asia Pacific Cluster at Advanced Accelerator Applications SA. Mr. Ortiz holds a graduate degree from the University of Seville and the University of Reims Champagne-Ardenne.
He also has an MBA from Kenan-Flagler Business School.
Postes actifs de Raphaël Ortiz
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01/01/2022 |
Anciens postes connus de Raphaël Ortiz
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Corporate Officer/Principal | - |
Formation de Raphaël Ortiz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Seville
University of Seville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Reims Champagne-Ardenne
University of Reims Champagne-Ardenne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advanced Accelerator Applications SA
Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
Kenan-Flagler Business School
Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
















